Add BrightSurf on Google Email

Targeting ABC transporters in PDAC – past, present, or future?

Researchers from Leiden University discuss targeting ABC transporters in pancreatic ductal carcinoma (PDAC), a cancer with poor survival rates. The authors highlight the potential of inhibiting ABC transporters to overcome chemoresistance and suggest developing stratification protocols to identify patients most likely to benefit.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateJul 10, 2024

Master autoimmune regulator gets by with a little help from its friends

Scientists at St. Jude Children's Research Hospital have reclassified Foxp3 as a transcriptional cofactor, revealing its reliance on DNA-binding proteins to regulate the immune system. This discovery has significant implications for future T-cell engineering and potentially treating autoimmune diseases.

SourceSt. Jude Children's Research Hospital·JournalJournal of Experimental Medicine·TypeExperimental study·DateJun 27, 2024

Determining sex in ants

A noncoding gene has been identified as the deciding factor in determining sex in Argentine ants, with a specific genomic region being crucial to this process. The gene does not encode a protein but rather produces an RNA that influences sex determination.

SourceJohannes Gutenberg Universitaet Mainz·JournalScience Advances·DateJun 6, 2024

UAB researchers uncover protein SRSF1’s uncommon ability to bind and unfold RNA G-quadruplexes

Researchers at the University of Alabama at Birmingham have discovered that the protein SRSF1 can bind and unfold complex RNA Guanine-quadruplexes. This finding could provide new avenues for treating illnesses such as cancer, which is often linked to misfunctioning splicing processes.

SourceUniversity of Alabama at Birmingham·JournalNucleic Acids Research·TypeData/statistical analysis·DateMay 30, 2024

Transgenic expression of rubisco factors increases photosynthesis and chilling tolerance in maize

Scientists at Boyce Thompson Institute have developed a method to enhance Rubisco production in maize, increasing carbon assimilation and boosting plant height. The transgenic plants also showed improved resilience to chilling stress, maintaining higher photosynthetic rates during cold exposure.

SourceBoyce Thompson Institute·JournalJournal of Experimental Botany·TypeExperimental study·DateMay 28, 2024

Kallistatin contributes to the beneficial metabolic effects of weight loss

Researchers found that Kallistatin expression increases after weight loss in individuals with overweight and obesity. Additionally, human Kallistatin improves hepatic insulin sensitivity in diet-induced obese mice. The study suggests that Kallistatin may be an interesting therapeutic target for people with obesity and type 2 diabetes.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalMolecular Metabolism·TypeExperimental study·DateMay 13, 2024

Cover paper: Senescent characteristics of human corneal endothelial cells upon UV-A exposure

Researchers investigate senescence phenotypes of human corneal endothelial cells upon treatment with ultraviolet (UV)-A. Cells exhibit enlarged morphology, increased β-galactosidase activity and decreased proliferation. UV-A-induced senescent cells show similar gene expression profiles to ionizing radiation (IR)-induced cells.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateApr 30, 2024

Spanish scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

Researchers discovered that eliminating progerin from vascular smooth muscle cells prevents atherosclerosis and improves life expectancy in HGPSrev mice. This finding suggests a potential therapeutic strategy for treating progeria, an extremely rare genetic disease affecting 1 in every 20 million people.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 22, 2024

New mechanism discovered for the life-threatening arrhythmias in Andersen-Tawil syndrome

Researchers have discovered a direct link between the C122Y mutation in the Kir2.1 potassium channel and life-threatening arrhythmias in Andersen-Tawil syndrome, which affects fewer than 1 in a million people. The study highlights the importance of understanding the molecular mechanisms underlying cardiac arrhythmias.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation Research·TypeExperimental study·DateApr 10, 2024

Connecting the dots to shape growth forces

Researchers at Kyoto University have discovered a signal protein called ERK that plays an active role in causing growing lung tissue to curve. This finding reveals a previously unknown regulatory system governing the development of intricate branching patterns in mouse lungs.

SourceKyoto University·JournalCurrent Biology·TypeExperimental study·DateMar 27, 2024

Milk to the rescue for diabetics? Cow produces human insulin in milk

Researchers have successfully created a transgenic cow capable of producing human insulin in its milk. This breakthrough could lead to the mass production of insulin without the need for complex facilities or infrastructure. With further testing and FDA approval, this technology has the potential to revolutionize insulin production and...

Researchers uncover a potential genetic marker associated with better survival outcomes in patients with head and neck cancer

A study published in Cancer Research Communications reveals a potential genetic marker associated with better survival outcomes in patients with head and neck cancer. The researchers found that the presence of a specific genetic variant and higher expression of the GAN gene product gigaxonin may contribute to improved survival rates.

SourceUniversity of California - Los Angeles Health Sciences·JournalCancer Research Communications·DateFeb 29, 2024

Study reveals mechanism that aggravates tuberculosis and reduces survival rates

Researchers found that an imbalance of CD4+ T cells in the lungs can exacerbate tuberculosis, leading to increased disease severity and reduced survival rates. Removing a specific receptor that recognizes extracellular ATP can improve the response of these T cells and potentially lead to new therapeutic interventions.

Novel therapeutic target overcomes resistance to radiation therapy

Researchers discovered a novel therapeutic target BAMBI that suppresses immune cells, reducing the effectiveness of radiation therapy and inducing therapy resistance in cancer patients. BAMBI's expression is associated with improved survival rates, suggesting it as a promising approach to overcome radiation therapy resistance.

SourceUniversity of Chicago Medical Center·JournalJournal of Clinical Investigation·TypeExperimental study·DateDec 15, 2023

Revisiting gene dosage

A study by Max Planck researchers has discovered an epigenetic regulator MSL2 that ensures the expression of both alleles of haploinsufficient genes, crucial for human health. This mechanism allows for tissue- and cell-type specificity in gene dosage, opening new directions for understanding diseases and developing potential treatments.

SourceMax Planck Institute of Immunobiology and Epigenetics·JournalNature·TypeExperimental study·DateNov 29, 2023

Cancer's sweet Achilles heel

A team of researchers at Kyoto University has found that a deficiency in the enzyme B4GALT3 inhibits tumor growth in mice. The study shows that reduced glycosylation on T cell surfaces correlates with increased CD8+ immune cells infiltrating tumors.

SourceKyoto University·JournalFrontiers in Immunology·TypeExperimental study·DateOct 25, 2023

BNP peptide a culprit in eczema

The brain natriuretic peptide (BNP) is a peptide that plays a crucial role in activating atopic dermatitis, or eczema. In a mouse model of AD, mice without BNP exhibited reduced thickened skin and itching compared to control mice with BNP.

SourceNorth Carolina State University·JournalJournal of Investigative Dermatology·TypeRandomized controlled/clinical trial·DateOct 19, 2023

Roots of Bloody Mary

Scientists have identified a bacterial strain that can break down the toxic tomatine in tomato roots, providing new understanding of how soil microbes interact with plants. This discovery could lead to the development of new bioactive compounds for human applications.

SourceKyoto University·JournalmBio·TypeExperimental study·DateOct 5, 2023

Targeting unsuspected protein reverses lymphedema

A Cornell-led collaboration created a 3D in-vitro model of human lymphatic vessels that revealed a surprising mechanism jamming up drainage: the protein ROCK2. Inhibiting ROCK2 reverses lymphedema effects, offering potential treatment for this condition.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateOct 3, 2023